(HSY) Hershey - Overview
Stock: Chocolate, Confectionery, Snacks, Gum, Pantry
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.27% |
| Yield on Cost 5y | 4.13% |
| Yield CAGR 5y | 12.59% |
| Payout Consistency | 95.8% |
| Payout Ratio | 119.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 37.1% |
| Relative Tail Risk | -3.27% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.59 |
| Alpha | 59.04 |
| Character TTM | |
|---|---|
| Beta | 0.064 |
| Beta Downside | 0.025 |
| Drawdowns 3y | |
|---|---|
| Max DD | 45.25% |
| CAGR/Max DD | 0.04 |
Description: HSY Hershey January 28, 2026
The Hershey Company (HSY) manufactures and sells a broad portfolio of confectionery, salty-snack, and pantry products across three operating segments-North America Confectionery, North America Salty Snacks, and International-serving wholesale, retail, and food-service channels in roughly 80 countries.
In the most recent quarter (Q2 FY2024), Hershey reported net sales of $3.20 billion, up 5.1 % year-over-year, driven primarily by price-realization gains that offset modest volume softness; operating margin expanded to 16.2 % (vs. 15.4 % a year ago) and diluted earnings per share reached $2.70. The company’s “ONE Bar” protein-snack line grew at a 14 % compound annual rate since launch, while its “SkinnyPop” popcorn brand posted a 9 % sales increase in the quarter.
Key macro drivers include persistent inflation in cocoa and sugar commodities (the Bloomberg Cocoa Index has risen ~12 % YTD), which pressures input costs, and a broader consumer shift toward higher-protein and lower-sugar snack options that is expanding the total addressable market for Hershey’s non-chocolate categories. At the same time, discretionary spending trends remain sensitive to real-wage growth and employment stability, factors that can moderate demand for premium confectionery.
For a deeper, data-driven assessment of Hershey’s valuation and risk profile, a quick look at the company’s metrics on ValueRay may uncover additional insights worth exploring.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 1.36b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.16 > 0.02 and ΔFCF/TA 2.79 > 1.0 |
| NWC/Revenue: 10.19% < 20% (prev -5.86%; Δ 16.05% < -1%) |
| CFO/TA 0.17 > 3% & CFO 2.29b > Net Income 1.36b |
| Net Debt (4.58b) to EBITDA (2.26b): 2.02 < 3 |
| Current Ratio: 1.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (203.5m) vs 12m ago 0.23% < -2% |
| Gross Margin: 37.46% > 18% (prev 0.44%; Δ 3701 % > 0.5%) |
| Asset Turnover: 87.70% > 50% (prev 86.93%; Δ 0.77% > 0%) |
| Interest Coverage Ratio: 8.79 > 6 (EBITDA TTM 2.26b / Interest Expense TTM 201.2m) |
Altman Z'' 3.41
| A: 0.09 (Total Current Assets 4.40b - Total Current Liabilities 3.23b) / Total Assets 13.58b |
| B: 0.40 (Retained Earnings 5.45b / Total Assets 13.58b) |
| C: 0.14 (EBIT TTM 1.77b / Avg Total Assets 13.10b) |
| D: 0.60 (Book Value of Equity 5.42b / Total Liabilities 9.01b) |
| Altman-Z'' Score: 3.41 = A |
Beneish M -3.09
| DSRI: 0.81 (Receivables 966.4m/1.14b, Revenue 11.49b/10.97b) |
| GMI: 1.18 (GM 37.46% / 44.35%) |
| AQI: 0.94 (AQ_t 0.42 / AQ_t-1 0.45) |
| SGI: 1.05 (Revenue 11.49b / 10.97b) |
| TATA: -0.07 (NI 1.36b - CFO 2.29b) / TA 13.58b) |
| Beneish M-Score: -3.09 (Cap -4..+1) = AA |
What is the price of HSY shares?
Over the past week, the price has changed by +18.89%, over one month by +29.14%, over three months by +39.18% and over the past year by +56.97%.
Is HSY a buy, sell or hold?
- StrongBuy: 3
- Buy: 1
- Hold: 17
- Sell: 2
- StrongSell: 2
What are the forecasts/targets for the HSY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 198.4 | -14.3% |
| Analysts Target Price | 198.4 | -14.3% |
| ValueRay Target Price | 258.3 | 11.6% |
HSY Fundamental Data Overview February 03, 2026
P/E Forward = 28.4091
P/S = 3.4374
P/B = 8.4651
P/EG = 48.5713
Revenue TTM = 11.49b USD
EBIT TTM = 1.77b USD
EBITDA TTM = 2.26b USD
Long Term Debt = 4.68b USD (from longTermDebt, last quarter)
Short Term Debt = 763.6m USD (from shortTermDebt, last quarter)
Debt = 5.74b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.58b USD (from netDebt column, last quarter)
Enterprise Value = 44.07b USD (39.49b + Debt 5.74b - CCE 1.16b)
Interest Coverage Ratio = 8.79 (Ebit TTM 1.77b / Interest Expense TTM 201.2m)
EV/FCF = 20.42x (Enterprise Value 44.07b / FCF TTM 2.16b)
FCF Yield = 4.90% (FCF TTM 2.16b / Enterprise Value 44.07b)
FCF Margin = 18.78% (FCF TTM 2.16b / Revenue TTM 11.49b)
Net Margin = 11.84% (Net Income TTM 1.36b / Revenue TTM 11.49b)
Gross Margin = 37.46% ((Revenue TTM 11.49b - Cost of Revenue TTM 7.19b) / Revenue TTM)
Gross Margin QoQ = 31.58% (prev 30.45%)
Tobins Q-Ratio = 3.25 (Enterprise Value 44.07b / Total Assets 13.58b)
Interest Expense / Debt = 0.90% (Interest Expense 51.5m / Debt 5.74b)
Taxrate = 25.70% (95.6m / 371.9m)
NOPAT = 1.31b (EBIT 1.77b * (1 - 25.70%))
Current Ratio = 1.36 (Total Current Assets 4.40b / Total Current Liabilities 3.23b)
Debt / Equity = 1.26 (Debt 5.74b / totalStockholderEquity, last quarter 4.56b)
Debt / EBITDA = 2.02 (Net Debt 4.58b / EBITDA 2.26b)
Debt / FCF = 2.12 (Net Debt 4.58b / FCF TTM 2.16b)
Total Stockholder Equity = 4.62b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.38% (Net Income 1.36b / Total Assets 13.58b)
RoE = 29.44% (Net Income TTM 1.36b / Total Stockholder Equity 4.62b)
RoCE = 19.03% (EBIT 1.77b / Capital Employed (Equity 4.62b + L.T.Debt 4.68b))
RoIC = 12.99% (NOPAT 1.31b / Invested Capital 10.12b)
WACC = 5.45% (E(39.49b)/V(45.23b) * Re(6.15%) + D(5.74b)/V(45.23b) * Rd(0.90%) * (1-Tc(0.26)))
Discount Rate = 6.15% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.45%
[DCF Debug] Terminal Value 86.98% ; FCFF base≈1.96b ; Y1≈2.09b ; Y5≈2.54b
Fair Price DCF = 476.3 (EV 75.15b - Net Debt 4.58b = Equity 70.57b / Shares 148.2m; r=5.90% [WACC]; 5y FCF grow 7.85% → 2.90% )
EPS Correlation: -40.04 | EPS CAGR: -6.76% | SUE: 1.19 | # QB: 2
Revenue Correlation: 37.37 | Revenue CAGR: 8.71% | SUE: 0.55 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.84 | Chg30d=+0.022 | Revisions Net=+1 | Analysts=15
EPS next Year (2026-12-31): EPS=7.09 | Chg30d=+0.173 | Revisions Net=+9 | Growth EPS=+18.2% | Growth Revenue=+3.7%